Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Poloxime is a hydrolysis product of poloxin and is a non-ATP-competitive Plk1 inhibitor. It also has moderate Plk1 inhibitory activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 39.00 | |
5 mg | 5 days | $ 62.00 | |
10 mg | 5 days | $ 92.00 | |
25 mg | 5 days | $ 139.00 | |
50 mg | 5 days | $ 177.00 | |
100 mg | 5 days | $ 297.00 | |
1 mL * 10 mM (in DMSO) | 5 days | $ 68.00 |
Description | Poloxime is a hydrolysis product of poloxin and is a non-ATP-competitive Plk1 inhibitor. It also has moderate Plk1 inhibitory activity. |
In vitro | Poloxime (100 μM) suppresses phosphopeptide binding to the polo-box domain (PBD) of polo-like kinase 1 [2]. |
Molecular Weight | 179.22 |
Formula | C10H13NO2 |
CAS No. | 17302-61-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (557.97 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Poloxime 17302-61-3 Cell Cycle/Checkpoint PLK inhibitor inhibit